Candida albicans PROTEIN PROFILE CHANGES IN RESPONSE TO THE BUTANOLIC EXTRACT OF Sapindus saponaria L.
Authors:
- Adriana FioriniAFAdriana Fiorini
- Fabio Rogério RosadoFRFabio Rogério Rosado
- Eliane Martins da Silva BettegaEBEliane Martins da Silva Bettega
- Kátia Cristina Sibin MeloKMKátia Cristina Sibin Melo
- Caroline KukoljCKCaroline Kukolj
- Patrícia de Souza Bonfim-MendonçaPBPatrícia de Souza Bonfim-Mendonça
- Cristiane Suemi Shinobu-MesquitaCSCristiane Suemi Shinobu-Mesquita
- Luciana Dias GhiraldiLGLuciana Dias Ghiraldi
- Paula Aline Zanetti CampanerutPCPaula Aline Zanetti Campanerut
- Isis Regina Grenier CapociICIsis Regina Grenier Capoci
- Janine Silva Ribeiro GodoyJGJanine Silva Ribeiro Godoy
- Izabel Cristina Piloto FerreiraIFIzabel Cristina Piloto Ferreira
Open Access
- 1 January 2016
- journal article
- research article
- Published by FapUNIFESP (SciELO) in Revista do Instituto de Medicina Tropical de São Paulo
- Vol. 58, 25
Abstract
Candida albicans is an opportunistic human pathogen that is capable of causing superficial and systemic infections in immunocompromised patients. Extracts of Sapindus saponaria have been used as antimicrobial agents against various organisms. In the present study, we used a combination of two-dimensional polyacrylamide gel electrophoresis (2D-PAGE) and matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) to identify the changes in protein abundance of C. albicans after exposure to the minimal inhibitory concentration (MIC) and sub-minimal inhibitory concentration (sub-MIC) of the butanolic extract (BUTE) of S. saponaria and also to fluconazole. A total of six different proteins with greater than 1.5 fold induction or repression relative to the untreated control cells were identified among the three treatments. In general, proteins/enzymes involved with the glycolysis (GPM1, ENO1, FBA1), amino acid metabolism (ILV5, PDC11) and protein synthesis (ASC1) pathways were detected. In conclusion, our findings reveal antifungal-induced changes in protein abundance of C. albicans. By using the previously identified components of the BUTE of S. saponaria(e.g., saponins and sesquiterpene oligoglycosides), it will be possible to compare the behavior of compounds with unknown mechanisms of action, and this knowledge will help to focus the subsequent biochemical work aimed at defining the effects of these compounds.Keywords
This publication has 26 references indexed in Scilit:
- Candida albicans: A Model Organism for Studying Fungal PathogensISRN Microbiology, 2012
- In vivo activity of Sapindus saponaria against azole-susceptible and -resistant human vaginal Candida speciesBMC Complementary and Alternative Medicine, 2011
- Changes in the Proteome of Candida albicans in Response to Azole, Polyene, and Echinocandin Antifungal AgentsAntimicrobial Agents and Chemotherapy, 2010
- Farnesol-Induced Apoptosis in Candida albicansAntimicrobial Agents and Chemotherapy, 2009
- Proteomic analysis of cytoplasmic and surface proteins from yeast cells, hyphae, and biofilms of Candida albicansProteomics, 2009
- Antifungal activity of the extracts and saponins from Sapindus saponaria L.Anais da Academia Brasileira de Ciências, 2007
- Proteomics for the analysis of the Candida albicans biofilm lifestyleProteomics, 2006
- Two New Antifungal Saponins from the Tibetan Herbal MedicineClematis tanguticaPlanta Medica, 2003
- Drug induced proteome changes in Candida albicans: Comparison of the effect of β(1,3) glucan synthase inhibitors and two triazoles, fluconazole and itraconazoleProteomics, 2003
- Antifungal Activity of Modified Hederagenin Glycosides from the Leaves of Kalopanax pictum var. chinense.Biological and Pharmaceutical Bulletin, 2001